In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats

References

• Assaad E, Wang YJ, Zhu XX, Mateescu MA. (2011). Polyelectrolyte complex of carboxymethyl starch and chitosan as drug carrier for oral administration. Carbohydr Polym 84:1399
   Web of Science ®Google Scholar
• Atjanasuppat K, Wongkham W, Meepowpan P, et al. (2009). In vitro screening for anthelmintic and antitumour activity of ethnomedicinal plants from Thailand. J Ethnopharmacol 123:475–82
   PubMed Web of Science ®Google Scholar
• Bird RP. (1987). Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37:147–51
   PubMed Web of Science ®Google Scholar
• Bowers LD. (1980). Kinetic plasma creatinine assays I. The role of various factors in determining specificity. Clin Chem 26:551–4
   PubMed Web of Science ®Google Scholar
• Bradley DW, Maynard JE, Emery G, Webster H. (1972). Transaminase activities in plasma of long-term hemodialysis patients. Clin Chem 18:1442
   PubMed Web of Science ®Google Scholar
• Chabner BA, Allegra CJ, Curt GA, Calabresi P. (1996). Anti-neoplastic agents. In: Hardman JG, Limbird LE, Berry PM, Raymond WR, eds. Goodman and Gilman’s the pharmacological basis of therapeutics. New Delhi: McGraw-Hil, p. 1233–87
   Google Scholar
• Chourasia MK, Jain SK. (2004a). Polysaccharides for colon targeted drug delivery. Drug Deliv 11:129–48
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. (2004b). Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv 11:201–7
   PubMed Web of Science ®Google Scholar
• Copur S, Aiba K, Drake JC, et al. (1995). Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem Pharmacol 49:1419–26
   PubMed Web of Science ®Google Scholar
• Djordjeuic B, Lange CS, Allison RR, Rotman M. (1993). Response of primary colon cancer cells in hybrid spheroids to 5-fluorouracil. Cancer Invest 11:291–3
   PubMed Web of Science ®Google Scholar
• Doumas BT, Byase DD, Carter RJ, et al. (1981). A candidate reference method for determination of total protein in plasma. I. Development and validation. Clin Chem 27/10:1642–50
   Web of Science ®Google Scholar
• Du J, Dai J, Liu J, Dankovich T. (2006). Novel pH-sensitive polyelectrolyte carboxymethyl Konjac glucomannan-chitosan beads as drug carriers. React Funct Polym 66:1055
   Web of Science ®Google Scholar
• Fiala ES. (1977). Investigation into metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine and azoxymethane. Cancer 40:2436–45
   PubMed Web of Science ®Google Scholar
• Fiala ES, Sohn OS, Hamilton SR. (1987). Effects of chronic dietary ethanol on the in vivo and in vitro metabolism of methylazoxymethanol and on methylazoxymethanol induced DNA methylation in the rat colon and liver. Cancer Res 47:5939–43
   PubMed Web of Science ®Google Scholar
• Fischel JL, Etienne MC, Spector T, et al. (1995). Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation. Clin Cancer Res 1:991–6
   PubMed Web of Science ®Google Scholar
• Freshney I. (1994). Culture of animal cells. New York: Wiley-Liss
   Google Scholar
• Ganguly K, Aminabhavi TM, Kulkarni AR. (2011). Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Ind Eng Chem Res 50:11797–807
   Web of Science ®Google Scholar
• Ghorab DM, Amin MM, Khowessah OM, Tadros MI. (2011). Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats. Drug Deliv 18:523–35
   PubMed Web of Science ®Google Scholar
• Herrmann R. (1993). Systemic treatment of colorectal cancer. Eur J Cancer 29A:583–6
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Utoh M, Sawada N, et al. (1998). Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol 55:1091–7
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin 61:69–90
   PubMed Web of Science ®Google Scholar
• Kaur G, Jain S, Tiwary AK. (2010). Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery. Sci Pharm 78:57
   PubMedGoogle Scholar
• Kulkarni AR, Hukkeri VI, Sung HW, Liang HF. (2005). A novel method for the synthesis of the PEG-crosslinked chitosan with a pH independent swelling behavior. Macromol Biosci 5:925
   PubMed Web of Science ®Google Scholar
• Labianca RF, Beretta GD, Pessi MA. (2001). Colorectal cancer: disease management considerations. Drugs 61:1751–64
   PubMed Web of Science ®Google Scholar
• LaMont JT, O’Gorman TA. (1978). Experimental colon cancer. Gastroenterology 75:1157–69
   PubMed Web of Science ®Google Scholar
• Li W, Li CB. (2003). Lack of inhibitory effect of lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rat. World J Gastroenterol 9:2469–73
   PubMed Web of Science ®Google Scholar
• Li P, Wang Y, Zeng F, et al. (2011). Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res 346:801
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Liu F, Zhang Z. (2007). Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. J Biomed Mater Res Part A 83:806
   PubMed Web of Science ®Google Scholar
• Meropol NJ. (1998). Oral fluoropyrimidines in the treatment of colorectal cancer. Eur J Cancer 34:1509–13
   PubMed Web of Science ®Google Scholar
• Moss DW, Henderson AR. (1999). Clinical enzymology. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: WB Saunders Co, p. 652
   Google Scholar
• Mundargi RC, Patil SA, Agnihotri SA, Aminabhavi TM. (2007). Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis. Drug Dev Ind Pharm 33:255–64
   PubMed Web of Science ®Google Scholar
• Preezel NC, Webling DDA. (1971). The length and mucosal surface area of the small and large gut in young rat. J Anat 108:295–6
   PubMed Web of Science ®Google Scholar
• Rahman Z, Kohli K, Zhang SQ, et al. (2008). In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J Pharm Pharmacol 60:615–23
   PubMed Web of Science ®Google Scholar
• Rai G, Yadav AK, Jain NK, Agarwal GP. (2014). Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.913733
   Web of Science ®Google Scholar
• Ramasamy T, Ruttala HB, Shanmugam S, Umadevi SK. (2013). Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis. Drug Deliv 20:65–77
   PubMed Web of Science ®Google Scholar
• Routledge ED, Gorman S, Clark MR. (1994). Cell and tissue culture: laboratory procedures. New York: Wiley
   Google Scholar
• Sandle GI. (1998). Salt and water absorption in the human colon: a modern appraisal. Gut 43:294–9
   PubMed Web of Science ®Google Scholar
• Sareen R, Jain N, Rajkumari A, Dhar KL. (2014). pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.903534
   PubMed Web of Science ®Google Scholar
• Torchillin VP. (2007). Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9 :E128–47
   PubMed Web of Science ®Google Scholar
• Torchillin VP. (1998). Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 15:1–19
   PubMed Web of Science ®Google Scholar
• Wei H, Qing D, De-Ying C, et al. (2008). Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm 348:35–45
   PubMed Web of Science ®Google Scholar
• Yan C, Gu J, Guo Y, Chen D. (2010). In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles. Yakugaku Zasshi 130:801–4
   PubMed Web of Science ®Google Scholar
• Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1–15
   PubMed Web of Science ®Google Scholar
• Yoon SS, Eto S, Lin CM, et al. (1999). Mouse endostatin inhibits the formation of lung and liver metastasis. Cancer Res 59:6251–6
   PubMed Web of Science ®Google Scholar
• Zeng A, Dong K, Wang M, et al. (2015). Investigation of the colon-targeting, improvement on the side-effects and therapy on the experimental colitis in mouse of a resin microcapsule loading dexamethasone sodium phosphate. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2015.1046569
   Web of Science ®Google Scholar
• Zhang DY, Shen XZ, Wang JY, et al. (2008). Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice. World J Gastroenterol 14:3554
   PubMed Web of Science ®Google Scholar
• Zinutti C, Barberi-Heyob M, Hoffman M, Maincent P. (1998). In-vivo evaluation of sustained release microspheres of 5-FU in rabbits. Int J Pharm 166:231–4
   Web of Science ®Google Scholar